Larimar Therapeutics Inc.
LRMR | NASDAQ
$3.83
+$0.04 (+1.06%)
At close: Sep 21, 2026, 4:00 PM ET
$3.83
$0 (0.00%)
Pre-market:
Sep 22, 2026, 8:05 AM ET
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | 80K | 161K | 161K | 161K | 81K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | n/a | n/a | n/a | -80K | -161K | -161K | -161K | -81K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -178.99M | -172.43M | -172.5M | -139.77M | -108.54M | -105.34M | -90.89M | -73.76M | -65.83M | -50.86M | -41.76M | -38.04M | -36.21M | -35.28M | -36.53M | -35.17M | -43.39M | -47.25M | -50.47M | -55.78M | -49.38M | -48.24M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -172.61M | -166.01M | -165.67M | -132M | -99.79M | -95.23M | -80.6M | -64.77M | -58.34M | -45.08M | -36.95M | -33.38M | -32.64M | -32.94M | -35.36M | -35.06M | -43.55M | -47.49M | -50.64M | -55.71M | -49.18M | -47.9M |
Net Income | -172.61M | -166.01M | -165.67M | -132M | -99.79M | -95.23M | -80.6M | -64.77M | -58.34M | -45.08M | -36.95M | -33.38M | -32.64M | -32.94M | -35.36M | -35.06M | -43.55M | -47.49M | -50.64M | -55.71M | -49.18M | -47.9M |
Selling & General & Admin | 21.75M | 19.82M | 18.37M | 18.28M | 17.96M | 18.45M | 17.61M | 16.57M | 15.98M | 14.81M | 14.09M | 13.8M | 12.97M | 12.27M | 12.28M | 11.85M | 11.62M | 12.02M | 12.07M | 13.1M | 13.81M | 12.86M |
Research & Development | 157.34M | 152.7M | 154.22M | 121.59M | 90.58M | 86.89M | 73.2M | 57.03M | 49.69M | 35.89M | 27.59M | 24.24M | 23.24M | 23.01M | 24.25M | 23.32M | 31.77M | 35.23M | 38.4M | 42.68M | 35.57M | 35.37M |
Other Expenses | -100K | -100K | -100K | -100K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 178.99M | 172.43M | 172.5M | 139.77M | 108.54M | 105.34M | 90.81M | 73.6M | 65.67M | 50.69M | 41.68M | 38.04M | 36.21M | 35.28M | 36.53M | 35.17M | 43.39M | 47.25M | 50.47M | 55.78M | 49.38M | 48.24M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | 100K | 100K | 100K | 100K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 178.99M | 172.43M | 172.5M | 139.77M | 108.54M | 105.34M | 90.89M | 73.76M | 65.83M | 50.86M | 41.76M | 38.04M | 36.21M | 35.28M | 36.53M | 35.17M | 43.39M | 47.25M | 50.47M | 55.78M | 49.38M | 48.24M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 103.88M | 85.18M | 85.18M | 78.32M | 64.03M | 63.96M | 63.81M | 63.81M | 63.8M | 53.55M | 43.91M | 43.9M | 43.9M | 43.9M | 23.99M | 22.23M | 18.34M | 18.34M | 18.34M | 18.29M | 16M | 16M |
Shares Outstanding (Diluted) | 103.88M | 85.18M | 85.18M | 78.32M | 64.03M | 63.96M | 63.81M | 63.81M | 63.8M | 53.55M | 43.91M | 43.9M | 43.9M | 43.9M | 23.99M | 22.23M | 18.34M | 18.34M | 18.34M | 18.29M | 16M | 16M |
EPS (Basic) | -1.99 | -2.10 | -2.21 | -1.93 | -1.56 | -1.49 | -1.30 | -1.15 | -1.12 | -0.97 | -0.82 | -0.87 | -1.03 | -1.31 | -1.68 | -1.83 | -2.38 | -2.70 | -2.97 | -3.36 | -3.08 | -3.50 |
EPS (Diluted) | -1.99 | -2.10 | -2.21 | -1.93 | -1.56 | -1.49 | -1.30 | -1.15 | -1.12 | -0.97 | -0.82 | -0.87 | -1.03 | -1.31 | -1.68 | -1.83 | -2.38 | -2.70 | -2.97 | -3.36 | -3.08 | -3.50 |
EBITDA | -172.3M | -165.68M | -165.32M | -131.66M | -99.46M | -94.91M | -80.29M | -64.45M | -58.01M | -44.76M | -36.64M | -33.07M | -32.33M | -32.62M | -35.04M | -34.74M | -43.21M | -47.16M | -50.33M | -55.63M | -49.2M | -48.03M |
EBIT | -172.61M | -166.01M | -165.67M | -132M | -99.79M | -95.23M | -80.6M | -64.77M | -58.34M | -45.08M | -36.95M | -33.38M | -32.64M | -32.94M | -35.36M | -35.06M | -43.55M | -47.49M | -50.65M | -55.92M | -49.45M | -48.24M |
Depreciation & Amortization | 301K | 326K | 350K | 340K | 326K | 326K | 318K | 322K | 324K | 313K | 311K | 308K | 309K | 314K | 318K | 328K | 339K | 335K | 326K | 288K | 250K | 205K |
Add to Watchlist
Select watchlists to add or remove LRMR